Monday, March 03, 2025 | 01:03 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aarti Drugs hits fresh all-time high; stock zooms 165% in 3 months

According to analysts at Centrum Broking, the launch of new products would improve the company's margins in the coming quarters

pharma, medicines, drugs
Premium

Aarti Drugs' Q4FY20 net profit more-than-doubled on a YoY basis

SI Reporter Mumbai
Shares of Aarti Drugs rallied 10 per cent on Friday to a new all-time high of Rs 1,299.50 on the BSE on expectation of good growth from its API (Active Pharmaceutical Ingredient) and formulation business.

In the past three months, the stock has zoomed 166 per cent, as compared to 17 per cent rise in the S&P BSE Sensex. At 11:24 am, it was up 7 per cent at Rs 1,262, against 0.6 per cent gain in the benchmark index.

For the January-March quarter (Q4FY20), Aarti Drugs' net profit more-than-doubled on a year-on-year basis to Rs 58.90 crore,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in